Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Chie Kudo-Saito

5PUBLICATIONS
14CO-AUTHORS
Molecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

Sort by Publication Date:
|Mar 14, 2026
IL10RB expression in cancer cells is associated with evolutionary changes to solidify treatment resistance.

Chie Kudo-Saito, Hiroki Ozawa, Hiroshi Imazeki

|Feb 02, 2026
ANGPTL3 in the Peripheral Circulation Is Associated with Resistance to Anti-PD1 Therapy in Advanced Gastric Cancer.

Chie Kudo-Saito, Hirokazu Shoji, Kengo Nagashima

|Oct 17, 2025
IL33-ST2 axis is a predictive biomarker for anti-PD1 therapeutic efficacy in advanced gastric cancer.

Chie Kudo-Saito, Hiroshi Imazeki, Kengo Nagashima

|Nov 03, 2024
Myeloid subsets impede the efficacy of anti-PD1 therapy in patients with advanced gastric cancer (WJOG10417GTR study).

Hirokazu Shoji, Chie Kudo-Saito, Kengo Nagashima

|Jul 15, 2021
CD11b<sup>+</sup>CTLA4<sup>+</sup> myeloid cells are a key driver of tumor evasion in colorectal cancer.

Hiroshi Imazeki, Yamato Ogiwara, Mami Kawamura

Pageof 1

Frequent Collaborators

2 joint publications

Kengo Nagashima

1 joint publications

Hirokazu Shoji

1 joint publications

Hiroshi Imazeki

1 joint publications

Kai Tsugaru

1 joint publications

Naoki Takahashi

1 joint publications

Takeshi Kawakami

1 joint publications

Yusuke Amanuma

1 joint publications

Takeru Wakatsuki

1 joint publications

Naohiro Okano

1 joint publications

Yukiya Narita

Frequent Collaborators

2 joint publications

Kengo Nagashima

1 joint publications

Hirokazu Shoji

1 joint publications

Hiroshi Imazeki

1 joint publications

Kai Tsugaru

Top Related Videos

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8<sup>+</sup> T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8<sup>+</sup> T Cells in Mice

Published on : Jun 12, 2021

7.8K
Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on : Sep 08, 2017

14.0K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

5.6K
See more related videos

Top Related Videos

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8<sup>+</sup> T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8<sup>+</sup> T Cells in Mice

Published on : Jun 12, 2021

7.8K
Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on : Sep 08, 2017

14.0K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

5.6K
See more related videos